Mounjaro Side Effects
Mounjaro side effects include nausea (18%), diarrhea (17%), and decreased appetite (11%) at diabetes doses. Generally well-tolerated with proper titration.
Nausea (5mg)
18%
Diarrhea (5mg)
17%
vs. Semaglutide GI
Comparable or lower
Hypoglycemia risk
With insulin/SU
Dose flexibility
6 strengths available
Side Effects at Diabetes Doses
Mounjaro side effects at the commonly prescribed diabetes doses (5mg-10mg) are generally milder than those seen at the maximum 15mg weight loss dose. In the SURPASS trials, common side effects at 5mg included: nausea (18%), diarrhea (17%), decreased appetite (11%), vomiting (6%), constipation (7%), and dyspepsia (8%).
At higher doses (10mg-15mg), these rates increase modestly. The dual GIP/GLP-1 mechanism may provide some GI protective effects, as tirzepatide's side effect rates are comparable to or lower than semaglutide despite producing greater weight loss.
Managing Mounjaro Side Effects
The same GI management strategies apply: smaller meals, avoid fatty foods, stay hydrated, and follow the titration schedule. The 2.5mg starting dose is purely for tolerance and should not be skipped. Many patients find the dose increases more tolerable than expected.
If side effects are significant at any dose, your provider can hold at that level for an additional 4 weeks. The wide dose range (6 strengths from 2.5mg to 15mg) allows more flexibility in finding the right balance of efficacy and tolerability.
Blood Sugar Monitoring
Because Mounjaro is primarily prescribed for diabetes, blood sugar monitoring is important during titration. The potent glucose-lowering effects, especially when combined with insulin or sulfonylureas, can increase hypoglycemia risk. Your provider may need to reduce doses of other diabetes medications as Mounjaro takes effect.
Monitor blood sugar more frequently during the first few weeks at each new Mounjaro dose, especially if you take other glucose-lowering medications.
Frequently Asked Questions
Is Mounjaro easier on the stomach than Ozempic?
Some data suggests tirzepatide (Mounjaro) has comparable or slightly lower GI side effect rates than semaglutide (Ozempic) at equivalent efficacy levels. Individual response varies.
Does Mounjaro cause low blood sugar?
Mounjaro alone rarely causes hypoglycemia because its insulin-stimulating effect is glucose-dependent. However, combining Mounjaro with insulin or sulfonylureas increases hypoglycemia risk.
What are the long-term side effects of Mounjaro?
Long-term data is still accumulating. The known class effects (GI symptoms, gallbladder disease, thyroid warnings) apply. The SURPASS-CVOT cardiovascular outcomes trial will provide additional long-term safety data.
Find providers specializing in Mounjaro management
Compare pricing, reviews, and availability across 18,000+ GLP-1 providers nationwide.
Search Providers →Explore all Tirzepatide topics
Cost guides, side effect management, dosing information, insurance coverage, and more — all backed by clinical data.